Drug Type Small molecule drug |
Synonyms PGE 9509924 |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors), TOP inhibitors(Topoisomerases inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H23N3O4 |
InChIKeyZASYVQUJFRKPOO-NSHDSACASA-N |
CAS Registry221221-39-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | United States | 07 Sep 2001 | |
Bacterial Infections | Preclinical | United States | - |